Review Article
Systematic Analysis of the Multiple Bioactivities of Green Tea through a Network Pharmacology Approach
Table 1
Enriched KEGG pathways.
| Pathway ID | Term | Number of proteins | P value |
| hsa05214 | Glioma | 21 | 8.86E − 11 | hsa05200 | Pathways in cancer | 39 | 2.41E − 09 | hsa05215 | Prostate cancer | 22 | 8.26E − 09 | hsa05223 | Non-small-cell lung cancer | 17 | 4.49E − 08 | hsa05218 | Melanoma | 18 | 6.21E − 07 | hsa04370 | VEGF signaling pathway | 15 | 9.00E − 06 | hsa05212 | Pancreatic cancer | 13 | 5.89E − 05 | hsa05213 | Endometrial cancer | 12 | 1.90E − 04 | hsa04115 | p53 signaling pathway | 12 | 2.39E − 04 | hsa05219 | Bladder cancer | 11 | 3.74E − 04 | hsa04914 | Progesterone-mediated oocyte maturation | 13 | 8.84E − 04 | hsa05222 | Small cell lung cancer | 14 | 8.84E − 04 | hsa04664 | Fc epsilon RI signaling pathway | 14 | 8.84E − 04 | hsa04510 | Focal adhesion | 20 | 1.16E − 03 | hsa04722 | Neurotrophin signaling pathway | 18 | 1.68E − 03 | hsa05220 | Chronic myeloid leukemia | 13 | 2.45E − 03 | hsa04660 | T cell receptor signaling pathway | 15 | 3.03E − 03 | hsa04012 | ErbB signaling pathway | 14 | 4.66E − 03 | hsa04666 | Fc gamma R-mediated phagocytosis | 11 | 6.31E − 03 | hsa04520 | Adherens junction | 9 | 7.74E − 03 | hsa04662 | B cell receptor signaling pathway | 11 | 1.28E − 02 | hsa05221 | Acute myeloid leukemia | 10 | 1.58E − 02 | hsa00140 | Steroid hormone biosynthesis | 8 | 2.15E − 02 | hsa04912 | GnRH signaling pathway | 15 | 2.43E − 02 | hsa05210 | Colorectal cancer | 9 | 2.99E − 02 | hsa05211 | Renal cell carcinoma | 11 | 3.47E − 02 |
|
|